In order to investigate the changes in the antibody response against ADAMTS13 during the course of TTP, we analyzed the amount, subclass distribution, and inhibitory potential of anti-ADAMTS13 autoantibodies in 101 samples of 81 TTP patients, drawn in different stages of the disease. Here, ADAMTS13 is linked to thrombotic thrombocytopenic purpura.